Evidence map›Paper›PMID 9420231›Full record

ArticleJournal of virology1998

Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus.

L Yuan, S Y Kang, L A Ward, T L To, L J Saif

Abstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Effects of benzoic acid,Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Protective Effects of Benzoic Acid,BioMed research international · 2018
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

L YuanDepartment of Veterinary Preventive Medicine, Ohio Agriculture Research and Development Center, The Ohio State University, Wooster 44691-4096, USA.
S Y Kang
L A Ward
T L To
L J Saif

Funding

ENHANCING THE IMMUNOGENICITY OF HUMAN ROTAVIRUS VACCINESR01AI033561 · NIAID · OHIO STATE UNIVERSITY · PI SAIF, LINDA J. · 1992 to 2006
$945k
IMMUNE RESPONSE TO ROTAVIRUS--MATERNAL ANTIBODIESR01AI037111 · NIAID · OHIO STATE UNIVERSITY · PI SAIF, LINDA J. · 1994 to 2003
$936k
NIAID NIH HHS R01 AI033561NIAID NIH HHS R01 AI037111NIAID NIH HHS R01AI33561NIAID NIH HHS R01AI37111
6 · The paper itself

Abstract

Newborn gnotobiotic pigs were inoculated twice perorally (p.o.) (group 1) or intramuscularly (i.m.) (group 2) or three times i.m. (group 3) with inactivated Wa strain human rotavirus and challenged with virulent Wa human rotavirus 20 to 24 days later. To assess correlates of protection, antibody-secreting cells (ASC) were enumerated in intestinal and systemic lymphoid tissues from pigs in each group at selected postinoculation days (PID) or postchallenge days. Few virus-specific ASC were detected in any tissues of group 1 pigs prior to challenge. By comparison, groups 2 and 3 had significantly greater numbers of virus-specific immunoglobulin M (IgM) ASC in intestinal and splenic tissues at PID 8 and significantly greater numbers of virus-specific IgG ASC and IgG memory B cells in spleen and blood at challenge. However, as for group 1, few virus-specific IgA ASC or IgA memory B cells were detected in any tissues of group 2 and 3 pigs. Neither p.o. nor i.m. inoculation conferred significant protection against virulent Wa rotavirus challenge (0 to 6% protection rate), and all groups showed significant anamnestic virus-specific IgG and IgA ASC responses. Hence, high numbers of IgG ASC or memory IgG ASC in the systemic lymphoid tissues at the time of challenge did not correlate with protection. Further, our findings suggest that inactivated Wa human rotavirus administered either p.o. or parenterally is significantly less effective in inducing intestinal IgA ASC responses and conferring protective immunity than live Wa human rotavirus inoculated orally, as reported earlier (L. Yuan, L. A. Ward, B. I. Rosen, T. L. To, and L. J. Saif, J. Virol. 70:3075-3083, 1996). Thus, more efficient mucosal delivery systems and rotavirus vaccination strategies are needed to induce intestinal IgA ASC responses, identified previously as a correlate of protective immunity to rotavirus.

Indexed as

Administration, OralAnimalsAnimals, NewbornAntibodies, ViralAntibody-Producing CellsB-LymphocytesGerm-Free LifeHumansImmunoglobulin AImmunologic MemoryInjections, IntramuscularIntestinesRotavirusRotavirus InfectionsSwineVaccines, InactivatedAntibodies, ViralImmunoglobulin AVaccines, InactivatedViral Vaccines

Identifiers

PMID9420231
PMCPMC109380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.